On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Medtronic (NYSE:MDT) said it has received European approval for its disposable continuous glucose monitor, the MidiMed 780G system with Simplera Sync sensor. The medical device maker said it was ...

The NIM-Response® 3.0 and NIM-Neuro® 3.0 offer advanced nerve monitoring technology with an easy-to-use interface. NIM® systems monitor EMG activity from multiple mucles. If there is a change ...

The first ever device to automatically monitor blood glucose and release the right levels of basal insulin has been approved in the US. Medtronic's MiniMed 670G hybrid closed loop system has been ...

The US Food and Drug Administration (FDA) has issued a Class I recall for Medtronic’s NIM Vital Nerve Monitoring System due ...

The Reveal LINQ monitor developed by Medtronic identifies more people who have atrial fibrillation after a cryptogenic stroke (CS) – with no identified cause – or transient ischaemic attack (TIA).

Remote monitoring for patients with implanted cardiac electrophysiology devices may finally be coming of age in the U.K. thanks to a review of these systems by the National Institute for Health and ...

Intraoperative NIM nerve monitoring systems enable surgeons to identify, confirm, and monitor motor nerve function to help reduce the risk of nerve damage during various procedures, including ENT ...

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...